The Serum Institute of India (SII), the world’s largest vaccine manufacturer based in Pune, has sought approval for another corona vaccine trial in India.
The Serum Institute has applied for the trial of Novavax’s Corona vaccine in India.
In the trial in England, this vaccine was shown to be 89.3 percent effective in preventing corona infection.
Expected to get trial approval soon – Poonawala
Significantly, Kovishield has been developed by AstraZeneca and Oxford University.
Serum Institute is trial and production in India under an agreement with AstraZeneca. Similarly, the Serum Institute has also tied up with the American company Novavax.
Adar Poonawala, the head of the Serum Institute, said that the company had applied for a vaccine trial a few days ago and is expected to get the approval soon.
Novavax may seek approval for emergency use in many countries
In England, 15,000 people aged 18–84 took part in the trial of this vaccine. There are speculations that the company may soon seek approval for emergency use of the vaccine in England, the European Union and other countries.
Foreign vaccine trials in India mandatory
According to the rules, local trials are necessary for any company seeking approval for use in India.
The government has imposed this condition because it wants to ensure that it is safe and effective for Indian citizens before they start using the vaccines because their genetic makeup may be different from that of people in Western countries.
However, in many cases, these conditions can also be waived.
Pfizer was not allowed due to non-trial
Due to this rule, Pfizer’s vaccine was not approved for emergency use in India.
Actually, Pfizer first sought approval to use its vaccine in India, but it did not want to do a trial in the country. Due to this, he could not get permission to use it.
On the other hand, Russia’s ‘Sputnik-V’ is conducting a third phase trial for approval of use in India. After this the company will apply for permission.
What is the status of epidemics and vaccination in India?
Corona infection has been confirmed in 1,07,20,048 people so far in India. Of these, 1,71,686 are active cases, 1,03,94,352 people have been cured after defeating the epidemic and 1,54,010 people have lost their lives due to this dangerous virus.
On the other hand, if you talk about the vaccination campaign, then the first dose of the corona vaccine has been administered to 29.28 lakh people in the country so far. The campaign is slowly gaining momentum.